Pull to refresh
Logo
Daily Brief
Following
Why Sign Up
Abbott Laboratories

Abbott Laboratories

Global Healthcare Company

Appears in 1 story

Stories

Abbott absorbs Exact Sciences, creating a cancer diagnostics giant

Money Moves

Acquirer

Abbott Laboratories closed its $21 billion acquisition of Exact Sciences on March 23, making the maker of the Cologuard colorectal cancer screening test a wholly owned subsidiary of one of the world's largest healthcare companies. The all-cash deal, at $105 per share, passed through antitrust review without a second request from regulators—a sign of how little the two companies' product lines overlapped before this combination.

Updated 2 hours ago